Page 3,037«..1020..3,0363,0373,0383,039..3,0503,060..»

MS Treatment Plan – Video

Posted: Published on December 5th, 2014

MS Treatment Plan Nov 4, 2014. By: Pamela Makela … Continue reading →

Posted in MS Treatment | Comments Off on MS Treatment Plan – Video

First MS patients treated with Genzymes Lemtrada in US

Posted: Published on December 5th, 2014

PBR Staff Writer Published 04 December 2014 Genzyme has announced that the first patient with relapsing forms of multiple sclerosis (MS) has been treated with Lemtrada (alemtuzumab). Due to its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS. Lemtrada has two annual treatment courses, the first is administered via intravenous infusion on five consecutive days, while the second is administered on three consecutive days, 12 months later. North Central Neurology Associates founder Christopher LaGanke said: "As an investigator in the Phase III clinical development program with firsthand experience, I have been awaiting the ability to prescribe Lemtrada to patients in my practice who could potentially benefit from this treatment. "Following REMS training and certification, I am excited that I was able to become the first physician to initiate patient treatment in the United States." In November, the FDA approved Lemtrada based on two pivotal randomized Phase III open-label rater-blinded studies comparing treatment with Lemtrada to Rebif in patients with relapsing remitting MS who were either new to treatment (CARE-MS I) or who had relapsed while on prior therapy (CARE-MS … Continue reading →

Posted in MS Treatment | Comments Off on First MS patients treated with Genzymes Lemtrada in US

MS Research Highlights in 2014 Offer New Leads in Stopping MS, Restoring Function Lost, and Ending MS Forever

Posted: Published on December 5th, 2014

NEW YORK, NY (PRWEB) December 04, 2014 Significant research progress occurred in 2014, offering new leads that are driving efforts to stop MS, restore function lost, and end MS forever. In 2014, the National Multiple Sclerosis Society invested $50.6 million in 380 new and ongoing research projects and initiatives. Here is a brief summary of the research highlights reflecting the Societys commitment to pursue promising opportunities wherever they exist, while focusing on three priority areas: progressive MS, nervous system repair, and wellness/lifestyle, which have been singled out under each research goal below when applicable. I. STOPPING MS ---Progressive MS--- ---Lifestyle/Wellness--- II. RESTORING WHATS BEEN LOST ---Nervous System Repair--- ---Lifestyle/Wellness--- III. ENDING MS FOREVER ---Lifestyle/Wellness--- Here is the original post: MS Research Highlights in 2014 Offer New Leads in Stopping MS, Restoring Function Lost, and Ending MS Forever … Continue reading →

Posted in MS Treatment | Comments Off on MS Research Highlights in 2014 Offer New Leads in Stopping MS, Restoring Function Lost, and Ending MS Forever

Side Effects Associated with Low T Prescription Drugs

Posted: Published on December 5th, 2014

Many men that suffer from low testosterone (also known as Low T) are taking hormone replacement therapy drugs that are linked to serious health concerns including heart attack and stroke. Several studies associate certain testosterone replacement therapy (TRT) drugs to an increased risk of cardiovascular problems such as heart attack, stroke, or deep vein thrombosis. Advocacy groups have called for updated black-box warnings to be included on all testosterone packages. These groups have also petitioned the U.S. Food and Drug Administration (FDA) to require Low T drug manufacturers to include warnings on the labels currently on the market. Testosterone Therapy and Use of Low T Drugs An estimated 3 to 7 percent of men in the U.S. have hypogonadism (low testosterone) a condition in which the body fails to produce enough hormones due to issues with the pituitary gland or testicles. However, with the advent of several Low T drugs on the market such as AndroGel, Androderm, Axiron, Delatestryl, Fortesta, Striant, Testim, Testopel among others thepercentage of men 40 and older being treated for Low T has more than tripled from 2001 to 2011, according to a USA Today article. The problem is that testosterone levels vary widely and is … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Side Effects Associated with Low T Prescription Drugs

Testosterone in women: How important is it?

Posted: Published on December 5th, 2014

Testosterone is another important hormone necessary for your personal hormonal symphony. Testosterone loss can occur at anytime in a woman's life. Deficiencies can begin with menopause but can also occur after childbirth. Hormone levels are often 'reset' after childbirth, however, not always correctly. Other factors that can lower testosterone levels include: chemotherapy, adrenal stress and burnout, endometriosis, depression, birth control pills, psychological trauma, and statin drugs. Deficiencies occur earlier and initially at a greater rate in women than in men. High amounts of testosterone are consumed, thereby depleting androgen levels, with intense physical activity such as long distance running as well as other vigorous sports. An optimal level of testosterone improves mood and assertiveness, reduces depression and anxiety, improves bone density, muscle size and strength, and enhances libido. It helps maintain memory; however, in a woman, effective levels of estrogen must also be present. It helps stop the skin from sagging, and decreases excess body fat. Symptoms of low testosterone include: muscle wasting, weight gain, fatigue, low self-esteem, decreased HDL cholesterol levels, dry and thin skin with poor elasticity, thinning and dry hair, droopy eyelids, sagging cheeks, thin lips and anxiety. Based on known effects of androgens, it is likely … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Testosterone in women: How important is it?

Stem Cell Research in Long QT Syndrome – Long QT Family Day | Boston Children’s Hospital – Video

Posted: Published on December 5th, 2014

Stem Cell Research in Long QT Syndrome - Long QT Family Day | Boston Children's Hospital Dr. William Pu, Assistant in Cardiology at Boston Children's Hospital, discusses stem cell research in long QT syndrome. Learn more: http://www.childrenshosp... By: Boston Children's Hospital … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem Cell Research in Long QT Syndrome – Long QT Family Day | Boston Children’s Hospital – Video

Persusive Video on Stem Cell Research – Video

Posted: Published on December 5th, 2014

Persusive Video on Stem Cell Research Song- Elements by Lindsey Stirling. By: edwin fane … Continue reading →

Posted in Stem Cell Research | Comments Off on Persusive Video on Stem Cell Research – Video

Research: NFL athletes are seeking unproven stem cell treatments

Posted: Published on December 5th, 2014

PUBLIC RELEASE DATE: 4-Dec-2014 Contact: David Ruth david@rice.edu 713-348-6327 Rice University @RiceUNews Some National Football League (NFL) players have been seeking out unproven stem cell therapies to help accelerate recoveries from injuries, according to a new paper from Rice University's Baker Institute for Public Policy. While most players seem to receive treatment within the United States, several have traveled abroad for therapies unavailable domestically and may be unaware of the risks involved, the paper found. The paper is published in the 2014 World Stem Cell Report, which is a special supplement to the journal Stem Cells and Development and is the official publication of the 2014 World Stem Cell Summit being held Dec. 3-5 in San Antonio. "With the rise of new and unproven stem cell treatments, the NFL faces a daunting task of trying to better understand and regulate the use of these therapies in order to protect the health of its players," said Kirstin Matthews, the Baker Institute fellow in science and technology policy and an expert on ethical and policy issues related to biomedical research and development. She co-authored the paper with Maude Rowland Cuchiara, the Baker Institute scholar for science and technology policy. Each year, more … Continue reading →

Posted in Stem Cell Research | Comments Off on Research: NFL athletes are seeking unproven stem cell treatments

Research to Prevent Blindness, Inc. and the International Retinal Research Foundation Announce Catalyst Awards for AMD …

Posted: Published on December 5th, 2014

Contact Information Available for logged-in reporters only Newswise New York, New York Research to Prevent Blindness (RPB), the leading eye research foundation, is partnering with the International Retinal Research Foundation (IRRF) to advance knowledge about age-related macular degeneration (AMD) through novel stem cell research. RPB/IRRF & RPB Sybil B. Harrington Catalyst Awards for Stem Cell Research Approaches for Age-Related Macular Degeneration (the Catalyst Awards) have been given to three leading researchers. Each will receive $250,000 over four years. Research related to both dry and wet forms of AMD is supported by these awards. Said RPB President Brian F. Hofland, PhD: The concept for these partnership grants evolved out of a significant gift that we received from an anonymous donor who wanted us to focus on stem cell research and AMD. It came with the condition that we would find matching funding. We found a valuable partner in the International Retina Research Foundation very quickly for two of the awards, and one we matched with bequest money that we received from the Sybil Harrington Estate a generous family that is committed to health-related research on several fronts. We are especially encouraged that this all came together at a key time in … Continue reading →

Posted in Stem Cell Research | Comments Off on Research to Prevent Blindness, Inc. and the International Retinal Research Foundation Announce Catalyst Awards for AMD …

Mini chromosomes that strengthen tumors

Posted: Published on December 5th, 2014

Cancers are due to genetic aberrations in certain cells that gain the ability to divide indefinitely. This proliferation of sick cells generates tumors, which gradually invade healthy tissue. Therefore, current therapies essentially seek to destroy cancer cells to stop their proliferation. Through high-throughput genetic sequencing of glioblastoma cells, one of the most deadly brain tumors, a team of geneticists from the University of Geneva's (UNIGE) Faculty of Medicine discovered that some of these mutations are caused by supplemental extrachromosomal DNA fragments, called double minutes, which enable cancer cells to better adapt to their environment and therefore better resist to treatments meant to destroy them. The work is published in Nature Communications. Although scientists have known for about twenty years about double minutes, little chromosomal fragments which sometimes appear during cellular division, they have just started to understand their exact function. Due to replication errors, these mini-chromosomes lack centromere, which allows them to replicate extremely rapidly and autonomously. Scientists therefore suspect that they play a role in the development of cancers, diseases that are caused by mutations in genes that control cellular metabolism and development. Professor Stylianos Antonarakis and his team in the Genetic Medicine and Development Department of UNIGE's Faculty … Continue reading →

Comments Off on Mini chromosomes that strengthen tumors

Page 3,037«..1020..3,0363,0373,0383,039..3,0503,060..»